FMP
KraneShares Emerging Markets Healthcare Index ETF
KMED
AMEX
Inactive Equity
The fund will invest at least 80% of its net assets in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.
18.81 USD
-0.5902 (-3.14%)
Historical Prices
From:
To:
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
https://kraneshares.com/KMEDexchange
AMEX
Description
The fund will invest at least 80% of its net assets in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.
CIK
0001547576
ISIN
US5007678197
CUSIP
500767819
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Oct 18, 2018
Sector Weightings
Country Weightings
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
KMED Financial Summary
ISIN
US5007678197
Exchange
AMEX
Beta
0.66
Market Cap
1.94M
52-Week
18.501-23.6367
Volume Avg.
129
Price
18.81
Country
US
Management Assets
1.95M
Total Holdings
17
NAV
18.93
NAV Currency
USD
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest KMED News
ETF Trends
Aug 13, 2021
China Calls for Global Cooperation, Pledges 2 Billion Covid-...
The Chinese government has promised 2 billion vaccines to help developing nations in the face of the highly contagious Covid-19 variant delta, as reported by the Wall Street Journal. President XI Jinping pledged the vaccines Thursday, while also calling for greater international cooperation in vaccine export and distribution.
ETF Trends
Jun 15, 2021
Access the Burgeoning Healthcare Sector Overseas with ‘KMED'
Emerging markets (EM) took their lumps from the Covid-19 pandemic, but as these economies re-emerge, look to strength in the healthcare sector with the KraneShares Emerging Markets Healthcare Index ETF (KMED). An increase in healthcare spending could boost the sector as the overall global population starts to age.
ETF Trends
Jun 4, 2021
As WHO Approves Second Chinese Covid-19 Vaccine, ‘KMED' Coul...
On Tuesday, the World Health Organization approved a Covid-19 vaccine produced by Sinovac Biotech for emergency use, the second vaccine created in China to be approved according to Reuters. That could be good news for the KraneShares Emerging Market Healthcare Index ETF (NYSE: KMED), which holds several Chinese pharmaceutical stocks.
Benzinga
Dec 10, 2020
3 Emerging Markets ETFs For 2021
One of the asset classes generating plenty of buzz as a 2021 idea is emerging markets. Up 4.5% over the past month, the MSCI Emerging Markets Index is already pricing in that enthusiasm.
SEEKINGALPHA
Apr 24, 2020
FDA cautions on use of malaria drugs for COVID-19 outside of...
In a statement, the FDA is cautioning against the use of malaria meds chloroquine and hydroxychloroquine outside of the hospital setting for the treatment of COVID-19 due to the risk of adverse heart
SEEKINGALPHA
Apr 21, 2020
Coronavirus cases 10x - 20x higher than reported - former FD...
Former FDA Commissioner Scott Gottlieb, M.D. is joining the growing chorus of experts who believe that the actual number of COVID-19 infections in the U.S. is substantially higher than reported, as mu
SEEKINGALPHA
Apr 17, 2020
U.S. COVID-19 testing capacity still constrained - AACC
In a statement, the American Association of Clinical Chemistry (AACC), a clinical laboratory industry group, says the scarcity of essential gear, including sample collection (nasal swabs) and
SEEKINGALPHA
Apr 5, 2020
Malaria drugs in high demand amid COVID-19
States across the U.S. are instituting measures to prevent hoarding of malaria drugs hydroxychloroquine and chloroquine in an effort to maintain supply amid acute demand from pharmacies and COVID-19 p
